Post-COVID syndrome (PCS) is associated with symptoms that persist after curing from SARS-CoV-2 infection. According to WHO, it is a disorder that typically requires at least 2 months to manifest before being diagnosed, and occurs 3 months after the initiation of COVID-19. Fatigue, dyspnea, headaches, joints, chest pains, abnormalities of taste and smell, coughing, hair loss, sleeplessness cardiac and gastrointestinal problems are examples of persistent symptoms. A cross-sectional study is with 325 participants from Benghazi. Prior to taking part in the trial, the individuals in this study had been infected with the coronavirus for at least two months. The majority of participants’ age was between 40 and 69 years, regarding the symptoms that were reported after infection. Fatigue was the most common response. Also, 71.4% of the participants had a mild infection The majority of patients received vitamins, analgesics, and minerals treatment (37.9%). The results were divided into a strong relationship with a significant p-value of less than (0.05) and a weak or insignificant (p-value > 0.05). In conclusion, fatigue, new loss of sense of taste, and smell and cough were the most common persistent symptoms in patients for a period of more than two months. Age and gender were a predictor for PCS while treatment protocol and symptoms such as cough, diarrhea, and headache were not a sign for PCS.
Cite this paper
Buzgeia, A. M. , Badi, N. H. S. , Ali, F. M. B. and Hamad, N. M. A. (2023). Cross-Sectional Perspective Study of Post-COVID Syndrome Characteristics in Benghazi, Libya. Open Access Library Journal, 10, e1004. doi: http://dx.doi.org/10.4236/oalib.1111004.
Zhou, P., Yang, X.L., Wang, X.G., Hu, B., Zhang, L., Zhang, W., Shi, Z.L., et al. (2020) Apneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin. Nature, 579, 270-273. https://doi.org/10.1038/s41586-020-2012-7
Singhal, T. (2020) A Review of Coronavirus Disease-2019 (COVID-19). The Indian Journal of Pediatrics, 87, 281-286. https://doi.org/10.1007/s12098-020-03263-6
Kampf, G., Todt, D., Pfaender, S. and Steinmann, E. (2020) Persistence of Coronaviruses on Inanimate Surfaces and Their Inactivation with Biocidal Agents. Journal of Hospital Infection, 104, 246-251. https://doi.org/10.1016/j.jhin.2020.01.022
Sharma, A., Tiwari, S., Deb, M.K. and Marty, J.L. (2020) Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): A Global Pandemic and Treatment Strategies. International Journal of Antimicrobial Agents, 56, Article ID: 106054.
https://doi.org/10.1016/j.ijantimicag.2020.106054
Rothan, H.A. and Byrareddy, S.N. (2020) The Epidemiology and Pathogenesis of Coronavirus Disease (COVID-19) Outbreak. Journal of Autoimmunity, 109, Article ID: 102433. https://doi.org/10.1016/j.jaut.2020.102433
Davis, H.E., et al. (2021) Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. eClinicalMedicine, 38, Article ID: 101019.
https://doi.org/10.1016/j.eclinm.2021.101019
Gao, Y.D., Ding, M., Dong, X., Zhang, J.J., KursatAzkur, A., Azkur, D. and Akdis, C.A. (2021) Risk Factors for Severe and Critically Ill COVID-19 Patients: A Review. Allergy, 76, 428-455. https://doi.org/10.1111/all.14657
Halpin, S.J., McIvor, C., Whyatt, G., Adams, A., Harvey, O., McLean, L., Sivan, M., et al. (2021) Postdischarge Symptoms and Rehabilitation Needs in Survivors of COVID-19 Infection: A Cross-Sectional Evaluation. Journal of Medical Virology, 93, 1013-1022. https://doi.org/10.1002/jmv.26368
Galal, I., Hussein, A.A., Amin, M.T., Saad, M.M., Zayan, H.E.E., Abdelsayed, M.Z., Hashem, M.K., et al. (2021) Determinants of Persistent Post-COVID-19 Symptoms: Value of a Novel COVID-19 Symptom Score. The Egyptian Journal of Bronchology, 15, Article No. 10. https://doi.org/10.1186/s43168-020-00049-4
Kayaaslan, B., Eser, F., Kalem, A.K., Kaya, G., Kaplan, B., Kacar, D., Guner, R., et al. (2021) Post-COVID Syndrome: A Single-Center Questionnaire Study on 1007 Participants Recovered from COVID-19. Journal of Medical Virology, 93, 6566-6574.？ https://doi.org/10.1002/jmv.27198
Augustin, M., Schommers, P., Stecher, M., et al. (2021) Post-COVID Syndrome in Non-Hospitalised Patients with COVID-19: A Longitudinal Prospective Cohort Study. The Lancet Regional Health—Europe, 6, Article ID: 100122.
https://doi.org/10.1016/j.lanepe.2021.100122
Sudre, C.H. (2021) Attributes and Predictors of Long-Covid: Analysis of Covid Cases and Their Symptoms Collected by the Covid Symptoms Study App. Nature Medecine, 27, 626-631. https://doi.org/10.1101/2020.10.19.20214494
Townsend, L., Dyer, A.H., Jones, K., Dunne, J., Mooney, A. and Gaffney, F (2020) Persistent Fatigue following SARS-CoV-2 Infection Is Common and Independent of Severity of Initial Infection. PLOS ONE, 15, e0240784.
https://doi.org/10.1371/journal.pone.0240784
Carvalho-Schneider, C., Laurent, E., Lemaignen, A., Beaufils, E., Bourbao-Tournois, C. and Laribi, S. (2021) Follow-Up of Adults with Noncritical COVID-19 Two Months after Symptom Onset. Clinical Microbiology and Infection, 27, 258-263.
https://doi.org/10.1016/j.cmi.2020.09.052
Lechien, J.R., Chiesa-Estomba, C.M., Place, S., Van Laethem, Y., Cabaraux, P. and Mat, Q. (2020) Clinical and Epidemiological Characteristics of 1420 European Patients with Mild-to-Moderate Coronavirus Disease 2019. Journal of Internal Medicine, 288, 335-344. https://doi.org/10.1111/joim.13089
Morgul, E., Bener, A., Atak, M., Akyel, S., Aktas, S., Bhugra, D., Jordan, T.R., et al. (2021) COVID-19 Pandemic and Psychological Fatigue in Turkey. International Journal of Social Psychiatry, 67, 128-135.
https://doi.org/10.1177/0020764020941889
Baig, A.M., Khaleeq, A., Ali, U. and Syeda, H. (2020) Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chemical Neuroscience, 11, 995-998.
https://doi.org/10.1021/acschemneuro.0c00122
Goertz, Y.M.J., Van Herck, M., Delbressine, J.M., Vaes, A.W., Meys, R. and Machado, F.V.C. (2020) Persistent Symptoms 3 Months after a SARS-CoV-2 Infection: The Post-COVID-19 Syndrome. ERJ Open Research, 6, 00542-2020.
Angelo, C., Bernabei, R., Landi, F. and Gemelli against COVID-19 Post-Acute Care Study Group (2020) Persistent Symptoms in Patients after Acute COVID-19. JAMA, 324, 603-605. https://doi.org/10.1001/jama.2020.12603
Delelegn, Y., Seboka, B.T., Tesfa, G.A., Mamo, T.T., Yawo, M.N. and Hailegebreal, S. (2022) Prevalence and Determinants of COVID-19 Vaccine Hesitancy among the Ethiopian Population: A Systematic Review. Risk Management and Healthcare Policy, 15, 1433-1445. https://doi.org/10.2147/RMHP.S368057
Bull-Otterson, L., Baca, S. and Saydah, S. (2022) Post-Covid Conditions among Adults COVID-19 Survivors Aged 18-64 and > 65 Years-United States. Morbidity and Mortality Weekly Report, 71, 713-717.
https://doi.org/10.15585/mmwr.mm7121e1
Peng, M., He, J., Xue, Y., Yang, X., Liu, S. and Gong, Z. (2021) Role of Hypertension on the Severity of COVID-19: A Review. Journal of Cardiovascular Pharmacology, 78, e648-e655. https://doi.org/10.1097/FJC.0000000000001116
Sen, S., Chakraborty, R., Kalita, P. and Pathak, M.P. (2021) Diabetes Mellitus and COVID-19: Understanding the Association in Light of Current Evidence. World Journal of Clinical Cases, 9, 8327-8339. https://doi.org/10.12998/wjcc.v9.i28.8327
Li, G., Deng, Q., Feng, J., Li, F., Xiong, N. and He, Q. (2020) Clinical Characteristics of COVID-19 Patients with and without Diabetes in Wuhan Red Cross Hospital. Journal of Diabetes Research, 2020, Article ID: 1652403.
https://doi.org/10.1155/2020/1652403
Xie, Y., Choi, T. and Al-Aly, Z. (2023) Association of Treatment with Nirmatrelvir and the Risk of Post-COVID-19 Condition. JAMA Internal Medicine, 183, 554-564.
https://doi.org/10.1001/jamainternmed.2023.0743
